Best-practice protocols: preventing adverse drug events.

Area of Science:

• Healthcare quality improvement
• Patient safety research
• Clinical informatics

Background:

• Intravenous patient-controlled analgesia (I.V.-PCA) is widely used for pain management.
• Unrecognized, low-frequency adverse events associated with I.V.-PCA can impact patient outcomes.
• Existing surveillance systems may not adequately capture these rare events.

Purpose of the Study:

• To identify unrecognized, low-frequency adverse events related to I.V.-PCA.
• To determine the root causes of these adverse events.
• To develop and implement solutions to mitigate risks associated with I.V.-PCA.

Main Methods:

• Analysis of data from Stanford's electronic Patient Safety Net.
• Application of a performance improvement-failure modes and effects analysis (PI-FMEA) methodology.
• Formation of a multidisciplinary team to review findings and propose solutions.

Main Results:

• A pattern of unrecognized, widespread, low-frequency I.V.-PCA adverse events was identified.
• The PI-FMEA successfully pinpointed contributing factors to these events.
• Specific causes were elucidated through systematic analysis.

Conclusions:

• Continuous monitoring and analysis of safety data are crucial for detecting rare adverse events.
• A systematic approach like PI-FMEA is effective in identifying causes of complex safety issues.
• Multidisciplinary collaboration is essential for developing and implementing effective patient safety solutions.